Search results

Page results

• Prostate One-Day Clinic

  This page explains more about the Prostate One-Day Clinic and what you can expect when you come for your appointment. If you have any questions about your appointment or the information included on this page, please contact one of our prostate clinical nurse specialists (CNSs).

• Ideas to improve food intake before and after your operation

  It is important to make sure you are eating and drinking well before your surgery. Good nutrition will also help you recover after your surgery.

• Thermoregulatory sweat test (TST)

  This page provides information about the thermoregulatory sweat test (TST).

• Can music therapy help patients recover from brain injury?

  A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.

• Transcervical ultrasound-guided radiofrequency ablation uterine fibroids (Sonata®)

  This provides information about a treatment for uterine fibroids known as ‘transcervical ultrasound-guided radiofrequency ablation’. You may also hear it called by the Manufacturer’s name ‘Sonata®’ for short.

• Changes in Breathing Pattern (Post-COVID Service)

  Patient information leaflet for patients suffering form long COVID who are experiencing breathlessness or changes in their breathing pattern.

• Relaxation Techniques (Post-COVID Service)

  This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.

• Series No 46 - Superficial radiotherapy treatment to the skin

  This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.

• Series No. 39 - Stereotactic ablative body radiotherapy (SABR) for lung cancer

  This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.

• UCLH patient first in world to receive a new investigational drug in a phase 1 trial

  A UCLH patient with a rare hormonal condition is the first in the world to receive a new investigational drug in a first-in-human trial.